Personalized dosing in prostate cancer treatment found to improve patient outcomes
By monitoring early-response biomarkers in men undergoing 177Lu-PSMA prostate cancer treatment, physicians can personalize dosing intervals, significantly improving patient outcomes.
Jun 27, 2023
0
17